The DOI matches its Crossref record; 248 of the 249 references it cites were found in a registry or an index.
Mechanisms and consequences of intestinal dysbiosis
Open accessAbstract
The composition of the gut microbiota is in constant flow under the influence of factors such as the diet, ingested drugs, the intestinal mucosa, the immune system, and the microbiota itself. Natural variations in the gut microbiota can deteriorate to a state of dysbiosis when stress conditions rapidly decrease microbial diversity and promote the expansion of specific bacterial taxa. The mechanisms underlying intestinal dysbiosis often remain unclear given that combinations of natural variations and stress factors mediate cascades of destabilizing events. Oxidative stress, bacteriophages induction and the secretion of bacterial toxins can trigger rapid shifts among intestinal microbial groups thereby yielding dysbiosis. A multitude of diseases including inflammatory bowel diseases but also metabolic disorders such as obesity and diabetes type II are associated with intestinal dysbiosis. The characterization of the changes leading to intestinal dysbiosis and the identification of the microbial taxa contributing to pathological effects are essential prerequisites to better understand the impact of the microbiota on health and disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Regardless of balance, intestinal microbiota affects the functionality of various organs such as brain, liver, pancreas, intestine, and heart (60, 61).”
From Kefir and Intestinal Microbiota Modulation: Implications in Human Health (2021) · cites this paper as [61]
In the citing paper
“In addition, the immune system and the intestinal microbiota play a symbiotic function, maintaining a picture of non-inflammatory homeostasis: in cases of intestinal dysbiosis, there is an activation of the immune system, which leads to changes in the host's immunity.”
From Kefir and Intestinal Microbiota Modulation: Implications in Human Health (2021) · cites this paper as [61]
In the citing paper
“These changes can impair the maturation of the innate immune system or lead to autoimmune diseases, such as type 1 diabetes (61).”
From Kefir and Intestinal Microbiota Modulation: Implications in Human Health (2021) · cites this paper as [61]
Citations
Cites
2 retracted
Items 201–248 of 248
Microbiota regulates type 1 diabetes through Toll-like receptors
Burrows, M. P., Volchkov, P., Kobayashi, K. S., & Chervonsky, A. V. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508740112 · Cited by 174
Li, L., & Zhao, X. (2015) · Scientific Reports · doi:10.1038/srep14682 · Cited by 167
Furuya‐Kanamori, L., Stone, J., Clark, J. M., McKenzie, S. J., Yakob, L., Paterson, D. L., Riley, T. V., Doi, S. A. R., & Clements, A. (2014) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2014.39 · Cited by 163
McDermott, P. F., Ciacci-Woolwine, F., Snipes, J. A., & Mizel, S. B. (2000) · Infection and Immunity · doi:10.1128/iai.68.10.5525-5529.2000 · Cited by 161
Sequencing the human microbiome in health and disease
Cox, M. J., Cookson, W. O. C. M., & Moffatt, M. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt398 · Cited by 159
Bile Acids and the Membrane Bile Acid Receptor TGR5—Connecting Nutrition and Metabolism
Thomas, C., Auwerx, J. H., & Schoonjans, K. (2008) · Thyroid · doi:10.1089/thy.2007.0255 · Cited by 155
Prevalence and Risk Factors for Asymptomatic Clostridium difficile Carriage
Alasmari, F. A., Seiler, S. M., Hink, T., Burnham, C. D., & Dubberke, E. R. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu258 · Cited by 152
Shankar, V., Gouda, M., Moncivaiz, J. D., Gordon, A., Reo, N. V., Hussein, L., & Paliy, O. (2017) · mSystems · doi:10.1128/msystems.00169-16 · Cited by 152
The role of toxin A and toxin B in the virulence of Clostridium difficile
Carter, G. P., Rood, J. I., & Lyras, D. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.11.003 · Cited by 148
Maele, L. V., Carnoy, C., Cayet, D., Songhet, P., Dumoutier, L., Ferrero, I., Janot, L., Erard, F., Bertout, J., Léger, H., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000115 · Cited by 144
TLR4 signalling in the intestine in health and disease
Fukata, M., & Abreu, M. T. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351473 · Cited by 142
Microcins in action: amazing defence strategies of Enterobacteria
Rebuffat, S. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120183 · Cited by 137
Gebhart, D., Lok, S., Clare, S., Tomas, M., Stares, M., Scholl, D., Donskey, C. J., Lawley, T. D., & Govoni, G. R. (2015) · mBio · doi:10.1128/mbio.02368-14 · Cited by 127
Murakami, Y., Tanabe, S., & Suzuki, T. (2015) · Journal of Food Science · doi:10.1111/1750-3841.13166 · Cited by 125
Scanlan, P. D., Shanahan, F., & Marchesi, J. R. (2009) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2009.00709.x · Cited by 124
Foster, J. P., Seth, R., & Cole, M. J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001816.pub3 · Cited by 111
Srinivasjois, R. M., Rao, S. C., & Patole, S. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.05.009 · Cited by 110
Escherichia coli Nissle 1917 in Ulcerative Colitis Treatment: Systematic Review and Meta-analysis
Losurdo, G., Iannone, A., Contaldo, A., Ierardi, E., Leo, A. D., & Principi, M. (2015) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld.2014.1121.244.ecn · Cited by 109
Liu, X., Blouin, J.-M., Santacruz, A., Lan, A., Andriamihaja, M., Wilkanowicz, S., Benetti, P.-H., Tomé, D., Sanz, Y., Blachier, F., et al. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00400.2013 · Cited by 103
Immunoglobulin-like domains on bacteriophage: weapons of modest damage?
Fraser, J. S., Maxwell, K. L., & Davidson, A. R. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2007.05.018 · Cited by 102
Kyogashima, M., Ginsburg, V., & Krivan, H. C. (1989) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(89)90042-8 · Cited by 102
Serum nitric oxide metabolites in subjects with metabolic syndrome
Zahediasl, S., Ghasemi, A., & Azizi, F. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.08.076 · Cited by 90
Structural insights into bacterial recognition of intestinal mucins
Etzold, S., & Juge, N. (2014) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2014.07.002 · Cited by 89
TNF-alpha Activates MUC2 Transcription via NF-kappaB but Inhibits via JNK Activation
Ahn, D. H., Crawley, S., Hokari, R., Kato, S., Yang, S. C., Li, J., & Kim, Y. (2005) · Cellular Physiology and Biochemistry · doi:10.1159/000083636 · Cited by 84
Non-Steroidal Anti-Inflammatory Drug-Induced Enteropathy
Lim, Y. J., & Yang, C. (2012) · Clinical Endoscopy · doi:10.5946/ce.2012.45.2.138 · Cited by 80
Space Environmental Factor Impacts upon Murine Colon Microbiota and Mucosal Homeostasis
Ritchie, L. E., Taddeo, S. S., Weeks, B. R., Lima, F., Bloomfield, S. A., Azcárate-Peril, M. A., Zwart, S. R., Smith, S. M., & Turner, N. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125792 · Cited by 80
The effects of the microbiota on the host immune system
Karczewski, J., Poniedziałek, B., Adamski, Z., & Rzymski, P. (2014) · Autoimmunity · doi:10.3109/08916934.2014.938322 · Cited by 73
Vasoactive intestinal peptide upregulates MUC2 intestinal mucin via CREB/ATF1
Hokari, R., Lee, H., Crawley, S., Yang, S. C., Gum, J. R., Miura, S., & Kim, Y. S. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00142.2005 · Cited by 68
Changes seen in gut bacteria content and distribution with obesity: causation or association?
Bell, D. S. H. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.1098519 · Cited by 67
Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells.
Doan, H. Q., Bowen, K. A., Jackson, L. A., & Evers, B. M. (2009) · PubMed · Cited by 67
Mahdavi, J., Pirinççioğlu, N., Oldfield, N. J., Carlsohn, E., Stoof, J., Aslam, A., Self, T. J., Cawthraw, S. A., Petrovska, L., Colborne, N., et al. (2014) · Open Biology · doi:10.1098/rsob.130202 · Cited by 64
Colonic bacterial metabolism of corticosteroids
Yadav, V., Gaisford, S., Merchant, H. A., & Basit, A. W. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.09.007 · Cited by 63
Wohlgemuth, S., Haller, D., Blaut, M., & Loh, G. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.01883.x · Cited by 54
Xin, B., Zheng, J., Liu, H., Li, J., Ruan, L., Peng, D., Sajid, M., & Sun, M. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01115 · Cited by 54
Demehri, F. R., Barrett, M., & Teitelbaum, D. H. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615609904 · Cited by 53
Drug metabolome of the Simvastatin formed by human intestinal microbiota in vitro
Aura, A., Mattila, I. M., Hyötyläinen, T., Gopalacharyulu, P. V., Bounsaythip, C., Orešič, M., & Oksman‐Caldentey, K. (2010) · Molecular BioSystems · doi:10.1039/c0mb00023j · Cited by 50
Rifaximin in the treatment of inflammatory bowel disease
Guslandi, M. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i42.4643 · Cited by 50
Cani, P. D., & Everard, A. (2014) · médecine/sciences · doi:10.1051/medsci/20143002003 · Cited by 48
The immunity–diet–microbiota axis in the development of metabolic syndrome
Brandsma, E. T., Houben, T., Fu, J., Shiri‐Sverdlov, R., & Hofker, M. H. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000154 · Cited by 48
The Interaction Between Celiac Disease and Intestinal Microbiota
Losurdo, G., Principi, M., Iannone, A., Ierardi, E., & Leo, A. D. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000682 · Cited by 45
Ihara, S., Hirata, Y., Serizawa, T., Suzuki, N., Sakitani, K., Kinoshita, H., Hayakawa, Y., Nakagawa, H., Ijichi, H., Tateishi, K., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502548 · Cited by 42
Wang, F., Sun, M. Y., Shi, S., & Lv, Z. S. (2013) · Colorectal Disease · doi:10.1111/codi.12290 · Cited by 35
The role of stress in colicin regulation
Ghazaryan, L., Tonoyan, L., Al‐Ashhab, A., Soares, M. I. M., & Gillor, O. (2014) · Archives of Microbiology · doi:10.1007/s00203-014-1017-8 · Cited by 32
The problem of nitrogen disposal in the obese
Alemany, M. (2012) · Nutrition Research Reviews · doi:10.1017/s0954422411000163 · Cited by 31
Scott, F. W., Pound, L. D., Patrick, C., Eberhard, C. E., & Crookshank, J. A. (2016) · Translational research · doi:10.1016/j.trsl.2016.09.001 · Cited by 24
Improving metabolic flux estimation via evolutionary optimization for convex solution space
Chen, J., Zheng, H., Liu, H., Junqing, N., Liu, J., Shen, T., Rui, B., & Shi, Y. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm050 · Cited by 11
Galdston, I. (1944) · Science · doi:10.1126/science.100.2587.76 · Cited by 3
Galdston, I. (1944) · Science · doi:10.1126/science.100.2587.76-a · Cited by 2
Cited by
Sorted by citations
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review
Di Vincenzo, F., Del Gaudio, A., Petito, V., Lopetuso, L. R., & Scaldaferri, F. (2024) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03374-w · Cited by 1,498
Hays, K. E., Pfaffinger, J. M., & Ryznar, R. J. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2393270 · Cited by 541
Layered defense: how mucus and tight junctions seal the intestinal barrier
Capaldo, C., Powell, D. N., & Kalman, D. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1557-x · Cited by 387
Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling
Hamamah, S., Aghazarian, A., Nazaryan, A., Hajnal, A. S., & Covașă, M. (2022) · Biomedicines · doi:10.3390/biomedicines10020436 · Cited by 327
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Shen, Y., Fan, N., Ma, S., Cheng, X., Yang, X., & Wang, G. (2025) · MedComm · doi:10.1002/mco2.70168 · Cited by 404
Metadata
- Authors
- Weiss, G. A., & Hennet, T.
- Affiliations
- University of Zurich (CH)
- Corresponding author
- Hennet, Thierry
- Venue
- Cellular and Molecular Life Sciences
- Published
- 2017-03-28
- Volume
- 74
- Issue
- 16
- Pages
- 2959-2977
- ISSN
- 1420-682X (ISSN-L)
- 1420-9071
- PMC
- PMC11107543
- OpenAlex
- W2599453585
- Cited by
- 775
- References
- 249
- Citations by year
- 2026: 86 · 2025: 145 · 2024: 124 · 2023: 112 · 2022: 121 · 2021: 72 · 2020: 59 · 2019: 30 · 2018: 18 · 2017: 7
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cellular and Molecular Life Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSII3_154488/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- gut dysbiosis, gut microbiota, microbial diversity, oxidative stress, bacteriophage induction, bacterial toxins, inflammatory bowel disease, obesity, type 2 diabetes, host-microbe interactions
- MeSH terms
- Gastrointestinal Microbiome, Animals, Diet, Pharmaceutical Preparations, Humans, Immunity, Intestinal Mucosa, Intestines, Oxidative Stress, Inflammasomes, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review